Vernalis (VER)

 

VER Share PerformanceMore

52 week high53.350 31/03/16
52 week low23.000 21/03/17
52 week change -27.870 (-52.84%)
4 week volume7,542,427 02/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - N+1 Singer issues a broker note on Vernalis PLC

N+1 Singer today reaffirms its hold investment rating on Vernalis PLC (LON:VER) and cut its price target to 28p (from 3...

Vernalis, Servier in new drug discovery collaboration

Vernalis and Servier have reinforced their partnership by entering into a new two-year oncology drug discovery collabora...

New drug discovery collaboration with Servier

Statement regarding an alliance between entities

Total Voting Rights

Notification of a change in the total number of voting rights

Unaudited interim results for 6 months to 31/12/16

Announcement of half-year/second quarter financial results

Broker Forecast - Stifel issues a broker note on Vernalis PLC

Stifel today reaffirms its buy investment rating on Vernalis PLC (LON:VER) and set its price target at 104p.

Achievement of a $3m milestone payment from Corvus

Vernalis schedules interims

Vernalis will announce its unaudited interim results for the six months ended 31 December on 21 February. At 1:03pm: (LO...

Fundamental DataMore

EPS-3.2
Dividend yield0 %

Equity Research (VER)

edison investment research
Vernalis plc
15/03/2017
Investment into addressing barriers to higher Tuzistra XR prescribing is starting to translate into higher prescription (Rx) rates. Mid-way through the second season post launch, both Rx and sales...
edison investment research
Vernalis plc
05/01/2017
FDA acceptance of the CCP-08 NDA (setting a 4 August 2017 PDUFA date) advances Vernalis towards its goal of building a speciality US franchise of extended release (ER) prescription-only (Rx) cough...
edison investment research
Vernalis plc
21/10/2016
Vernalis marked its transition into a commercial-stage speciality pharma company with the September 2015 US launch of Tuzistra XR, the first product from its extended release (ER) prescription only (...

Latest discussion posts More

  • Now Woody's Buying

    Just me and him then, anyone else? M
    26-Jul-2016
    sound money
  • More Director Buying.

    Wow these guys really believe this is a winner. Glad I bought in last week. M
    9-Jun-2016
    sound money
  • Edison Note - Research Tree

    Read Edison's note on VERNALIS, out this morning, by visiting https://www.research-tree.com/company/GB00B3Y5L754 "Vernalis intends to raise #40m (gross) through the issue of ...
    28-Apr-2016
    FoxRed

Users' HoldingsMore

Users who hold Vernalis also hold..
LLOYDS GRP.36%
BP20%
VODAFONE GRP.20%
BT GROUP19%
GLAXOSMITHKLINE19%

Codes & Symbols

ISINGB00B3Y5L754
SymbolsVER, LSE:VER, VER.L, VER:LN, LON:VER, XLON:VER